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We report an unusual case of human babesiosis in Fin-
land in a 53-year-old man with no history of splenectomy. 
He had a rudimentary spleen, coexisting Lyme borreliosis, 
exceptional dark streaks on his extremities, and subsequent 
disseminated aspergillosis. He was infected with Babe-
sia divergens, which usually causes bovine babesiosis in 
Finland.
B
abesiosis is an arthropod-transmitted infection caused 
by an apicomplexan parasite. Most zoonotic cases in 
humans have been reported from the eastern coast of the 
United States, where the causative agent is Babesia micro-
ti, which is transmitted from white-footed mice to humans 
by Ixodes scapularis ticks (1,2). Rare cases of human babe-
siosis caused by B. divergens have been reported in Europe. 
B. divergens is a bovine parasite transmitted mainly by I. 
ricinus ticks. Both Ixodes spp. ticks also transmit Borre-
lia burgdorferi, the etiologic agent of Lyme borreliosis. In 
certain areas of the United States, >10% of patients with a 
diagnosis of Lyme disease are co-infected with B. microti 
(3). Co-infections with Borrelia spp. and B. divergens in-
fections have been documented only serologically (4).
Babesia sporozoites are transmitted to the vertebrate 
host by a tick bite (5). The sporozoites invade erythrocytes 
and transform into ring-form trophozoites and typical Mal-
tese cross assemblies of merozoites. Parasites lyse infected 
erythrocytes, which release merozoites that can invade new 
erythrocytes (6,7). Trophozoites can alternatively develop 
into gametocytes, enabling continuation of the life cycle in 
the tick after it has had a blood meal.
Most disease manifestations of human babesiosis are 
related to hemolysis (1). Symptoms are anemia, malaise, 
fever, chills, myalgia, and fatigue. High parasitemia levels 
can cause massive hemoglobinuria, acute renal tubular ne-
crosis, and renal failure. In addition to hemolysis-associat-
ed manifestations, acute respiratory distress syndrome may 
occur as a complication and lead to death (8). B. divergens 
infections in Europe have been severe, and the mortality rate 
is high (42%) compared with that of B. microti infections 
in the United States (5%–20%) (1,2,9). All 22 published 
cases of B. divergens infection in Europe have occurred in 
patients who have undergone splenectomy (2). We report 
an unusual case of human babesiosis in Finland.
The Patient
A 53-year-old man was admitted to South Karelia 
Central Hospital in Lappeenranta, Finland, in September 
2004 with septic shock. The patient had a history of severe 
alcohol-induced pancreatitis (in 1993), subsequent type 1 
diabetes mellitus, Staphylococcus aureus septicemia (in 
2000), and atherosclerosis. He had had fever, back pain, 
and fatigue for a week before admission and reported that 
his urine was darker and lower in volume than usual for 
several days. The patient had no history of travel abroad in 
the past 5 years.
At admission, the patient was conscious. Physical ex-
amination and intensive care unit monitoring indicated sep-
tic shock and lactate acidosis. The Physiology and Chronic 
Health Evaluation score of the patient was 60%, and the 
Simpliﬁ  ed Acute Physiology score was 50%. The patient 
was treated with routine intensive care measures, which 
were started at admission.
Physical examination showed a wide (maximum di-
ameter 10 cm) erythema chronicum migrans (ECM) lesion 
on the left thigh (Figure 1, panel A) and dark streaks on 
both legs and the right arm (Figure 1, panels B, C). Dur-
ing the ﬁ  rst 24 hours, laboratory analyses showed massive 
hemolysis (plasma hemoglobin 2,650 mg/dL, blood hemo-
globin 5.7 g/dL, haptoglobin 30 mg/dL, lactic dehydroge-
nase 11,240 U/L, bilirubin 213 μmol/L), thrombocytopenia 
(thrombocyte count 56,000/μL), an elevated C-reactive 
protein level (13.9 mg/dL at admission), and an elevated 
aspartate aminotransferase level (9,559 U/L). Ultrasound 
showed a low signal from the spleen. Microscopic ex-
amination of a blood smear was conducted 25 hours after 
admission because of suspicion of hemolytic uremic syn-
drome and showed intraerythrocytic structures typical of 
babesiosis with a parasitemia level of ≈10% (Figure 2).
The patient was treated with intravenous quinine 
(1,000 mg 3×/d for 12 days), clindamycin (600 mg 4×/d 
for 12 days), and cefotaxime (2 g/d for 12 days). At the end 
of day 2, a 9-liter blood exchange was performed. Despite 
these procedures and reduction of the high level of para-
sitemia (to 1% within 2 days), the patient had hypotension 
and was treated in the intensive care unit in a respirator 
under propofol-based sedation. At day 9, he had pulmo-
nary aspergillosis (infection with Aspergillus fumigatus), 
S. epidermidis in blood cultures, and Candida albicans cul-
tured from the tip of his dialysis catheter. After the patient 
received a diagnosis of multiple organ failure, treatment 
was terminated on day 12; he died the same day. Histologic 
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analysis of autopsy specimens showed aspergillosis in the 
lungs, heart, and kidneys. The spleen was rudimentary, and 
no malignancy was found. The patient was HIV negative.
To identify Babesia spp., DNA was extracted from 
anticoagulated venous blood samples obtained on day 2. 
DNA was ampliﬁ  ed and the PCR product was sequenced 
as described (10). The sequence obtained (GenBank acces-
sion no. GU945501) was 100% identical to previously a 
reported B. divergens 18S rDNA sequence (GenBank ac-
cession no. AY789076.1).
Conclusions
We report an unusual human case of babesiosis and 
provide molecular evidence that the causative organism 
was B. divergens. Human babesiosis has not been previ-
ously reported in Finland. Eight fatal cases of babesiosis 
have been described in Europe (1 each in the former Soviet 
Union, France, Spain, and the former Yugoslavia, and 4 
in the British Isles) (2,11). All cases were B. divergens in-
fections in patients who had undergone splenectomy. This 
species has been identiﬁ  ed by inoculation into animals or 
by serologic analysis.
Bovine babesiosis is endemic to Finland, although its in-
cidence has dramatically decreased over the past 2 decades. 
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Figure 1. Lesions of the patient infected with Babesia divergens 
1 day after hospitalization, Finland, 2004. A) Left thigh showing a 
classical erythema chronicum migrans lesion; B) left leg and C) 
right arm showing dark purple streaks.
Figure 2. Giemsa-stained smears of peripheral blood of the patient 
infected with Babesia divergens, Finland, 2004. Intraerythrocytic 
parasites are indicated by arrows (A), and a representative Maltese 
cross form of the parasite is indicated by an arrowhead (B). (Original 
magniﬁ  cation ×750.)Monthly data for bovine babesiosis in Finland are obtained 
by municipal veterinarians who send reports to the Minis-
try of Agriculture and Forestry (T. Aaltonen, unpub. data). 
Three cases of bovine babesiosis were reported to health 
authorities in the municipality where the patient lived in the 
same year he was infected and became ill (online Appendix 
Figure, www.cdc.gov/EID/content/16/7/1116-appF.htm). 
The patient lived in the country next to a cattle farm. He 
took walks and worked in the forest nearby. Because the 
patient had no travel history, we conclude that babesiosis 
was acquired in Finland, and, most likely, locally from the 
zoonotic reservoir of B. divergens in cattle through a tick 
bite (Table). This conclusion is supported by the presence 
of ECM and a tick bite on the thigh of the patient. Infection 
with Babesia sp. and Borrelia sp. from the same tick bite is 
likely because ECM and babesiosis caused by B. divergens 
are manifested 3–30 days and 7–21 days, respectively, after 
a tick bite.
The poor outcome of the patient can be explained by 
several factors. His immune system was not intact. He 
also had diabetes, which impaired his general immunity. 
Although he had not undergone splenectomy, he was also 
considered asplenic because only a rudimentary spleen was 
found by autopsy. The rudimentary spleen may have been 
caused by severe pancreatitis or by high consumption of 
alcohol (12). Invasive aspergillosis, which is usually seen 
only in severely immunocompromised patients, also devel-
oped in the patient. The origin of dark streaks on his arms 
and legs is not clear but was probably caused by massive 
intravascular hemolysis, which was also suggested by dark 
urine. 
Co-infection with Babesia sp. and Borrelia sp. has 
been shown to cause disease with additional symptoms and 
a more persistent illness than infection with B. microti (3). 
This co-infection could have caused the severe and fatal 
disease in our patient. Thus, clinicians should be aware of 
co-infection with B. divergens and Borrelia sp.
This work was supported by the Academy of Finland (proj-
ect 128646), the Sigrid Jusélius Foundation, and Helsinki Univer-
sity Central Hospital.
Ms Haapasalo is a scientist at the Haartman Institute, Uni-
versity of Helsinki, Helsinki, Finland. Her research interest is mi-
crobial pathogenesis, speciﬁ  cally the role of innate immunity in 
parasitic and bacterial infections. 
References
  1.   Homer MJ, Aguilar-Delﬁ  n I, Telford SR III, Krause PJ, Persing DH. 
Babesiosis. Clin Microbiol Rev. 2000;13:451–69. DOI: 10.1128/
CMR.13.3.451-469.2000
  2.   Gorenﬂ  ot A, Moubri K, Precigout E, Carcy B, Schetters TP. Hu-
man babesiosis. Ann Trop Med Parasitol. 1998;92:489–501. DOI: 
10.1080/00034989859465
  3.   Krause PJ, Telford SR III, Spielman A, Sikand V, Ryan R, Christian-
son D, et al. Concurrent Lyme disease and babesiosis. Evidence for 
increased severity and duration of illness. JAMA. 1996;275:1657–
60. DOI: 10.1001/jama.275.21.1657
  4.   Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, et 
al. Seroprevalence of Babesia infections in humans exposed to ticks 
in midwestern Germany. J Clin Microbiol. 2002;40:2431–6. DOI: 
10.1128/JCM.40.7.2431-2436.2002
  5.   Karakashian SJ, Rudzinska MA, Spielman A, Lewengrub S, Pies-
man J, Shoukrey N. Ultrastructural studies on sporogony of Babesia 
microti in salivary gland cells of the tick Ixodes dammini. Cell Tis-
sue Res. 1983;231:275–87. DOI: 10.1007/BF00222180
  6.   Krampitz  HE.  Babesia microti: morphology, distribution and 
host relationship in Germany. Zentralbl Bakteriol [Orig A]. 
1979;244:411–5.
  7.   Rudzinska MA, Trager W, Lewengrub SJ, Gubert E. An electron 
microscopic study of Babesia microti invading erythrocytes. Cell 
Tissue Res. 1976;169:323–34. DOI: 10.1007/BF00219605
  8.   Benach JL, Habicht GS. Clinical characteristics of human babesio-
sis. J Infect Dis. 1981;144:481.
  9.   Vannier E, Krause PJ. Update on babesiosis. Interdiscip Perspect In-
fect Dis. 2009; 2009:984568. Epub 2009 Aug 27. 
10.   Herwaldt BL, Caccio S, Gherlinzoni F, Aspock H, Slemenda SB, 
Piccaluga P, et al. Molecular characterization of a non-Babesia di-
vergens organism causing zoonotic babesiosis in Europe. Emerg In-
fect Dis. 2003;9:942–8.
11.    Rabinovich SA, Voronina ZK, Stepanova NI, Maruashvili GM, 
Bakradze TL. 1st detection of human babesiasis in the USSR and 
a short analysis of the cases described in the literature [in Russian]. 
Med Parazitol (Mosk). 1978;47:97–107.
12.   Muller AF, Toghill PJ. Functional hyposplenism in alcoholic liver 
disease: a toxic effect of alcohol? Gut. 1994;35:679–82. DOI: 
10.1136/gut.35.5.679
Address for correspondence: T. Sakari Jokiranta, Haartman Institute, 
University of Helsinki, Haartmaninkatu 3, PO Box 21, Helsinki, Finland; 
email: sakari.jokiranta@helsinki.ﬁ  
DISPATCHES
1118  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 7, July 2010
Table. Incidence of cattle babesiosis, Finland* 
District 
Year 
1965 1975 2000 2002 2002 2003 2004 
Southern – – 21 7 23 6 11
Eastern† – – 39 31 27 28 18
O u l u  ––00000
Lapland  ––00000
Ahvenanmaa – – 18 12 18 2 0
W e s t e r n ––11662
Total 4,796 2,524  79 51 74 42 312
*–, no district data were available. 
†Region where the index case-patient lived.  